{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:02:50Z","timestamp":1790283770539,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873231"],"award-info":[{"award-number":["81873231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45476-3","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:32:51Z","timestamp":1774085571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palmatine ameliorates MASLD in type 2 diabetes by modulating hepatic apoptosis and inflammation"],"prefix":"10.1038","volume":"16","author":[{"given":"Huasen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoujing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"1","key":"45476_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (1), 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"45476_CR2","doi-asserted-by":"crossref","unstructured":"Konings, L. A. M. et al. Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review. Eur. J. Clin. Invest. 55(4), e70003 (2025).","DOI":"10.1111\/eci.70003"},{"issue":"4","key":"45476_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"EASL-EASD-EASO Clinical Practice Guidelines on the","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the. Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Obes. Facts. 17 (4), 374\u2013444 (2024).","journal-title":"Obes. Facts"},{"issue":"7","key":"45476_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J. & George, J. A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158 (7), 1999\u20132014e1 (2020).","journal-title":"Gastroenterology"},{"issue":"1","key":"45476_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12916-024-03696-2","volume":"22","author":"Y Ji","year":"2024","unstructured":"Ji, Y., Wang, Q., Jiang, Y. & Liu, B. Global epidemiology of T2DM in patients with NAFLD or MAFLD: the real situation may be even more serious. BMC Med. 22 (1), 476 (2024).","journal-title":"BMC Med."},{"issue":"1","key":"45476_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12916-024-03315-0","volume":"22","author":"L Cao","year":"2024","unstructured":"Cao, L. et al. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis. BMC Med. 22 (1), 101 (2024).","journal-title":"BMC Med."},{"issue":"4","key":"45476_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan, N. & Cusi, K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 10 (4), 284\u2013296 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"45476_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/jir.2022.0172","volume":"43","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Analysis of Immune and Inflammatory Microenvironment Characteristics of Noncancer End-Stage Liver Disease. J. Interferon Cytokine Res. 43 (2), 86\u201397 (2023).","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"45476_CR9","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell, P. B. et al. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arterioscler. Thromb. Vasc Biol. 42 (6), e168\u2013e185 (2022).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"45476_CR10","doi-asserted-by":"crossref","unstructured":"Sarker, J., Okpara, E., De Los Santos, B., Kim, M. & Kim, K. Comparative effectiveness of GLP-1 receptor agonists, SGLT2 inhibitors and DPP-4 inhibitors on liver outcomes in metabolic dysfunction-associated steatotic liver disease: A retrospective cohort study. Diabetes Obes. Metab. 28(4), 3155\u20133164 (2026).","DOI":"10.1111\/dom.70505"},{"issue":"11","key":"45476_CR11","first-page":"8308","volume":"13","author":"G Tong","year":"2020","unstructured":"Tong, G. et al. The efficacy of sulodexide combined with Jinshuibao for treating early diabetic nephropathy patients. Int. J. Clin. Exp. Med. 13 (11), 8308\u20138317 (2020).","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"45476_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/0004563216648250","volume":"53","author":"J Cegla","year":"2016","unstructured":"Cegla, J. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomized, placebo-controlled phase 2 study. Ann. Clin. Biochem. 53 (4), 518 (2016).","journal-title":"Ann. Clin. Biochem."},{"key":"45476_CR13","doi-asserted-by":"publisher","first-page":"1416403","DOI":"10.3389\/fphar.2024.1416403","volume":"15","author":"W Li","year":"2024","unstructured":"Li, W. et al. The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review. Front. Pharmacol. 15, 1416403 (2024).","journal-title":"Front. Pharmacol."},{"key":"45476_CR14","doi-asserted-by":"crossref","unstructured":"Choi, S. et al. Convergent metabolic pathways in MASH therapeutics: An AMPK-centric analysis. J. Cell. Mol. Med. 30(2), e71023 (2026).","DOI":"10.1111\/jcmm.71023"},{"issue":"1","key":"45476_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40659-020-00308-0","volume":"53","author":"X Tian","year":"2020","unstructured":"Tian, X. et al. Palmatine ameliorates high fat diet induced impaired glucose tolerance. Biol. Res. 53 (1), 39 (2020).","journal-title":"Biol. Res."},{"key":"45476_CR16","doi-asserted-by":"crossref","unstructured":"Nwabueze, O. P. et al. M. P., Comparative Studies of Palmatine with Metformin and Glimepiride on the Modulation of Insulin Dependent Signaling Pathway In Vitro, In Vivo & Ex Vivo. Pharmaceuticals (Basel) 15, (11). (2022).","DOI":"10.3390\/ph15111317"},{"key":"45476_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.biochi.2019.04.008","volume":"162","author":"J Long","year":"2019","unstructured":"Long, J. et al. Palmatine: A review of its pharmacology, toxicity and pharmacokinetics. Biochimie 162, 176\u2013184 (2019).","journal-title":"Biochimie"},{"key":"45476_CR18","doi-asserted-by":"publisher","first-page":"155005","DOI":"10.1016\/j.phymed.2023.155005","volume":"119","author":"X Yin","year":"2023","unstructured":"Yin, X., Liu, Z. & Wang, J. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Phytomedicine 119, 155005 (2023).","journal-title":"Phytomedicine"},{"key":"45476_CR19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.2147\/DDDT.S356307","volume":"16","author":"JJ Cheng","year":"2022","unstructured":"Cheng, J. J. et al. Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-\u03baB\/NLRP3 and Nrf2 Pathways. Drug Des. Devel Ther. 16, 2119\u20132132 (2022).","journal-title":"Drug Des. Devel Ther."},{"issue":"Pt 1","key":"45476_CR20","doi-asserted-by":"publisher","first-page":"114886","DOI":"10.1016\/j.ejmech.2022.114886","volume":"245","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR). Eur. J. Med. Chem. 245 (Pt 1), 114886 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"45476_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.fitote.2014.08.006","volume":"98","author":"JS Choi","year":"2014","unstructured":"Choi, J. S. et al. Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C\/EBP-\u03b1 and PPAR-\u03b3. Fitoterapia 98, 199\u2013208 (2014).","journal-title":"Fitoterapia"},{"key":"45476_CR22","doi-asserted-by":"publisher","first-page":"1547131","DOI":"10.3389\/fphar.2025.1547131","volume":"16","author":"S Zhang","year":"2025","unstructured":"Zhang, S., Liu, K., Liu, Y., Hu, X. & Gu, X. The role and application of bioinformatics techniques and tools in drug discovery. Front. Pharmacol. 16, 1547131 (2025).","journal-title":"Front. Pharmacol."},{"key":"45476_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev.pharmtox.42.082401.140850","volume":"42","author":"RB Altman","year":"2002","unstructured":"Altman, R. B. & Klein, T. E. Challenges for biomedical informatics and pharmacogenomics. Annu. Rev. Pharmacol. Toxicol. 42, 113\u2013133 (2002).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"45476_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13755-025-00370-6","volume":"13","author":"Y Qian","year":"2025","unstructured":"Qian, Y., Wang, Q., Yin, L. & Lu, A. Y. CF-DTI: coarse-to-fine feature extraction for enhanced drug-target interaction prediction. Health Inf. Sci. Syst. 13 (1), 55 (2025).","journal-title":"Health Inf. Sci. Syst."},{"key":"45476_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru, J. et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 6, 13 (2014).","journal-title":"J. Cheminform"},{"issue":"W1","key":"45476_CR26","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45 (W1), W356\u2013w360 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45476_CR27","doi-asserted-by":"publisher","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","volume":"49","author":"S Fang","year":"2021","unstructured":"Fang, S. et al. HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 49 (D1), D1197\u2013d1206 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45476_CR28","doi-asserted-by":"publisher","first-page":"D1110","DOI":"10.1093\/nar\/gky1021","volume":"47","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res. 47 (D1), D1110\u2013d1117 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45476_CR29","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"UniProt","year":"2025","unstructured":"UniProt. the Universal Protein Knowledgebase in 2025. Nucleic Acids Res. 53 (D1), D609\u2013d617 (2025).","journal-title":"Nucleic Acids Res."},{"key":"45476_CR30","doi-asserted-by":"publisher","first-page":"109324","DOI":"10.1016\/j.envint.2025.109324","volume":"196","author":"M Cheng","year":"2025","unstructured":"Cheng, M. et al. Exploring the mechanism of PPCPs on human metabolic diseases based on network toxicology and molecular docking. Environ. Int. 196, 109324 (2025).","journal-title":"Environ. Int."},{"key":"45476_CR31","doi-asserted-by":"publisher","first-page":"1102581","DOI":"10.3389\/fphar.2023.1102581","volume":"14","author":"Q He","year":"2023","unstructured":"He, Q. et al. Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking. Front. Pharmacol. 14, 1102581 (2023).","journal-title":"Front. Pharmacol."},{"key":"45476_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough, E. & Barrett, T. The Gene Expression Omnibus Database. Methods Mol. Biol. 1418, 93\u2013110 (2016).","journal-title":"Methods Mol. Biol."},{"key":"45476_CR33","doi-asserted-by":"crossref","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).","DOI":"10.1093\/nar\/gkv007"},{"issue":"1","key":"45476_CR34","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1038\/s41467-018-07232-8","volume":"9","author":"SR Rosario","year":"2018","unstructured":"Rosario, S. R. et al. Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat. Commun. 9 (1), 5330 (2018).","journal-title":"Nat. Commun."},{"issue":"1","key":"45476_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","volume":"21","author":"H Qin","year":"2023","unstructured":"Qin, H. et al. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. J. Transl Med. 21 (1), 588 (2023).","journal-title":"J. Transl Med."},{"issue":"5","key":"45476_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12 (5), 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"45476_CR37","doi-asserted-by":"crossref","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177(7), 1888\u20131902e21 (2019).","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"45476_CR38","doi-asserted-by":"crossref","unstructured":"Zappia, L. & Oshlack, A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience 7, (7). (2018).","DOI":"10.1093\/gigascience\/giy083"},{"issue":"3","key":"45476_CR39","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"X Xiong","year":"2019","unstructured":"Xiong, X. et al. Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. Mol. Cell. 75 (3), 644\u2013660e5 (2019).","journal-title":"Mol. Cell."},{"issue":"4","key":"45476_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32 (4), 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"issue":"7719","key":"45476_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. V., RNA velocity of single cells. Nature 560 (7719), 494\u2013498 (2018).","journal-title":"Nature"},{"key":"45476_CR42","doi-asserted-by":"publisher","first-page":"118405","DOI":"10.1016\/j.lfs.2020.118405","volume":"262","author":"Y Ning","year":"2020","unstructured":"Ning, Y., Xu, F., Xin, R. & Yao, F. Palmatine regulates bile acid cycle metabolism and maintains intestinal flora balance to maintain stable intestinal barrier. Life Sci. 262, 118405 (2020).","journal-title":"Life Sci."},{"issue":"5","key":"45476_CR43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ptr.5295","volume":"29","author":"N Ning","year":"2015","unstructured":"Ning, N. et al. Hypolipidemic Effect and Mechanism of Palmatine from Coptis chinensis in Hamsters Fed High-Fat diet. Phytother Res. 29 (5), 668\u2013673 (2015).","journal-title":"Phytother Res."},{"key":"45476_CR44","doi-asserted-by":"crossref","unstructured":"Tong, J., Ding, Y. & Zhang, D. Mechanisms of Actinidia chinensis Planch roots in the treatment of breast cancer based on network pharmacology and molecular docking. Med. (Baltim). 104(31), e43560 (2025).","DOI":"10.1097\/MD.0000000000043560"},{"issue":"1","key":"45476_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40203-024-00190-8","volume":"12","author":"AS de Oliveira","year":"2024","unstructured":"de Oliveira, A. S., Muniz Seif, E. J. & da Silva Junior, P. I. In silico prospection of receptors associated with the biological activity of U1-SCTRX-lg1a: an antimicrobial peptide isolated from the venom of Loxosceles gaucho. Silico Pharmacol. 12 (1), 15 (2024).","journal-title":"Silico Pharmacol."},{"issue":"D1","key":"45476_CR46","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013d677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"45476_CR47","doi-asserted-by":"publisher","first-page":"154887","DOI":"10.1016\/j.phymed.2023.154887","volume":"126","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine 126, 154887 (2024).","journal-title":"Phytomedicine"},{"issue":"3","key":"45476_CR48","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bbalip.2018.12.012","volume":"1864","author":"AB Singh","year":"2019","unstructured":"Singh, A. B., Dong, B., Xu, Y., Zhang, Y. & Liu, J. Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1864 (3), 358\u2013371 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"45476_CR49","doi-asserted-by":"crossref","unstructured":"Schuster-Gaul, S. et al. ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. JCI Insight 5, (2). (2020).","DOI":"10.1172\/jci.insight.123294"},{"issue":"6","key":"45476_CR50","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","volume":"140","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140 (6), 900\u2013917 (2010).","journal-title":"Cell"},{"key":"45476_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","volume":"332","author":"J Pan","year":"2018","unstructured":"Pan, J. et al. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. Cell. Immunol. 332, 111\u2013120 (2018).","journal-title":"Cell. Immunol."},{"issue":"6","key":"45476_CR52","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134 (6), 1655\u20131669 (2008).","journal-title":"Gastroenterology"},{"issue":"3","key":"45476_CR53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","volume":"79","author":"F Wang","year":"2024","unstructured":"Wang, F. et al. Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1\u03b1 transcriptional complex. Hepatology 79 (3), 606\u2013623 (2024).","journal-title":"Hepatology"},{"issue":"8","key":"45476_CR54","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/liv.15967","volume":"44","author":"Y Duan","year":"2024","unstructured":"Duan, Y. et al. Crosstalk in extrahepatic and hepatic system in NAFLD\/NASH. Liver Int. 44 (8), 1856\u20131871 (2024).","journal-title":"Liver Int."},{"issue":"2","key":"45476_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/advances\/nmy084","volume":"10","author":"W Ren","year":"2019","unstructured":"Ren, W. et al. Glutamine Metabolism in Macrophages: A Novel Target for Obesity\/Type 2 Diabetes. Adv. Nutr. 10 (2), 321\u2013330 (2019).","journal-title":"Adv. Nutr."},{"issue":"4","key":"45476_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/dmrr.2580","volume":"31","author":"J Liu","year":"2015","unstructured":"Liu, J., Wang, G., Jia, Y. & Xu, Y. GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease. Diabetes Metab. Res. Rev. 31 (4), 329\u2013335 (2015).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"45476_CR57","doi-asserted-by":"publisher","first-page":"117163","DOI":"10.1016\/j.biopha.2024.117163","volume":"177","author":"J He","year":"2024","unstructured":"He, J. et al. Graveoline attenuates D-GalN\/LPS-induced acute liver injury via inhibition of JAK1\/STAT3 signaling pathway. Biomed. Pharmacother. 177, 117163 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"45476_CR58","first-page":"66","volume":"17","author":"J Hindson","year":"2020","unstructured":"Hindson, J. Obeticholic acid for the treatment of NASH. Nat. Rev. Gastroenterol. Hepatol. 17 (2), 66 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"45476_CR59","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1590-8658(02)80033-0","volume":"34","author":"ME Guicciardi","year":"2002","unstructured":"Guicciardi, M. E. & Gores, G. J. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig. Liver Dis. 34 (6), 387\u2013392 (2002).","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"45476_CR60","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s42255-023-00746-6","volume":"5","author":"M Angelim","year":"2023","unstructured":"Angelim, M. & Moraes-Vieira, P. M. Glycolysis modulates efferocytosis in a noncanonical manner. Nat. Metab. 5 (3), 360\u2013361 (2023).","journal-title":"Nat. Metab."},{"issue":"9","key":"45476_CR61","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.18632\/oncotarget.3131","volume":"6","author":"HG Hambright","year":"2015","unstructured":"Hambright, H. G., Meng, P., Kumar, A. P. & Ghosh, R. Inhibition of PI3K\/AKT\/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells. Oncotarget 6 (9), 7195\u20137208 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"45476_CR62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12916-025-04390-7","volume":"23","author":"J Yu","year":"2025","unstructured":"Yu, J. et al. Extracellular vesicles derived from menstrual blood-derived mesenchymal stem cells suppress inflammatory atherosclerosis by inhibiting NF-\u03baB signaling. BMC Med. 23 (1), 565 (2025).","journal-title":"BMC Med."},{"issue":"4","key":"45476_CR63","doi-asserted-by":"publisher","first-page":"109883","DOI":"10.1016\/j.celrep.2021.109883","volume":"37","author":"H Mohammadpour","year":"2021","unstructured":"Mohammadpour, H., MacDonald, C. R., McCarthy, P. L., Abrams, S. I. & Repasky, E. A. \u03b22-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Cell. Rep. 37 (4), 109883 (2021).","journal-title":"Cell. Rep."},{"issue":"6","key":"45476_CR64","first-page":"3915","volume":"14","author":"Q Zhang","year":"1994","unstructured":"Zhang, Q., Didonato, J. A., Karin, M. & McKeithan, T. W. BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. Mol. Cell. Biol. 14 (6), 3915\u20133926 (1994).","journal-title":"Mol. Cell. Biol."},{"issue":"7","key":"45476_CR65","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/01616412.2023.2176633","volume":"45","author":"F Wu","year":"2023","unstructured":"Wu, F., Zhang, P. & Zhou, G. The involvement of EGR1 in neuron apoptosis in the in vitro model of spinal cord injury via BTG2 up-regulation. Neurol. Res. 45 (7), 646\u2013654 (2023).","journal-title":"Neurol. Res."},{"issue":"1","key":"45476_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.regpep.2006.07.011","volume":"138","author":"X Li","year":"2007","unstructured":"Li, X., Meng, Y., Wu, P., Zhang, Z. & Yang, X. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat. Regul. Pept. 138 (1), 15\u201325 (2007).","journal-title":"Regul. Pept."},{"key":"45476_CR67","doi-asserted-by":"publisher","first-page":"115494","DOI":"10.1016\/j.taap.2021.115494","volume":"418","author":"KC Wu","year":"2021","unstructured":"Wu, K. C. et al. Tpl2 kinase regulates inflammation but not tumorigenesis in mice. Toxicol. Appl. Pharmacol. 418, 115494 (2021).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"45476_CR68","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1535-6108(03)00280-0","volume":"4","author":"A Fleischmann","year":"2003","unstructured":"Fleischmann, A., Jochum, W., Eferl, R., Witowsky, J. & Wagner, E. F. Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell. 4 (6), 477\u2013482 (2003).","journal-title":"Cancer Cell."},{"issue":"Suppl 1","key":"45476_CR69","doi-asserted-by":"publisher","first-page":"i109","DOI":"10.1136\/ard.2010.140533","volume":"70","author":"HB Schonthaler","year":"2011","unstructured":"Schonthaler, H. B., Guinea-Viniegra, J. & Wagner, E. F. Targeting inflammation by modulating the Jun\/AP-1 pathway. Ann. Rheum. Dis. 70 (Suppl 1), i109\u2013i112 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"45476_CR70","doi-asserted-by":"crossref","unstructured":"Liu, S. et al. Melatonin mitigates aflatoxin B1-induced liver injury via modulation of gut microbiota\/intestinal FXR\/liver TLR4 signaling axis in mice. J. Pineal Res. 73(2), e12812 (2022).","DOI":"10.1111\/jpi.12812"},{"issue":"Pt 2","key":"45476_CR71","doi-asserted-by":"publisher","first-page":"124832","DOI":"10.1016\/j.ijbiomac.2023.124832","volume":"242","author":"AA Bhat","year":"2023","unstructured":"Bhat, A. A. et al. The pyroptotic role of Caspase-3\/GSDME signalling pathway among various cancer: A Review. Int. J. Biol. Macromol. 242 (Pt 2), 124832 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"45476_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.canlet.2021.07.014","volume":"520","author":"L Li","year":"2021","unstructured":"Li, L. et al. Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2\/caspase-8\/caspase-3\/GSDME axis. Cancer Lett. 520, 143\u2013159 (2021).","journal-title":"Cancer Lett."},{"key":"45476_CR73","doi-asserted-by":"publisher","first-page":"109967","DOI":"10.1016\/j.cbi.2022.109967","volume":"361","author":"RY Li","year":"2022","unstructured":"Li, R. Y. et al. Cisplatin-induced pyroptosis is mediated via the CAPN1\/CAPN2-BAK\/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer. Chem. Biol. Interact. 361, 109967 (2022).","journal-title":"Chem. Biol. Interact."},{"key":"45476_CR74","doi-asserted-by":"publisher","first-page":"921414","DOI":"10.3389\/fphar.2022.921414","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. PD-L1 Regulates Platelet Activation and Thrombosis via Caspase-3\/GSDME Pathway. Front. Pharmacol. 13, 921414 (2022).","journal-title":"Front. Pharmacol."},{"key":"45476_CR75","doi-asserted-by":"crossref","unstructured":"Mai, F. Y. et al. Caspase-3-mediated GSDME activation contributes to cisplatin- and doxorubicin-induced secondary necrosis in mouse macrophages. Cell. Prolif. 52(5), e12663 (2019).","DOI":"10.1111\/cpr.12663"},{"issue":"12","key":"45476_CR76","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.it.2018.10.005","volume":"39","author":"S Mouasni","year":"2018","unstructured":"Mouasni, S. & Tourneur, L. FADD at the Crossroads between Cancer and Inflammation. Trends Immunol. 39 (12), 1036\u20131053 (2018).","journal-title":"Trends Immunol."},{"issue":"20","key":"45476_CR77","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.4161\/cc.5.20.3385","volume":"5","author":"MH Werner","year":"2006","unstructured":"Werner, M. H., Wu, C. & Walsh, C. M. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell. Cycle. 5 (20), 2332\u20132338 (2006).","journal-title":"Cell. Cycle"},{"issue":"7232","key":"45476_CR78","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nature07606","volume":"457","author":"FL Scott","year":"2009","unstructured":"Scott, F. L. et al. The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457 (7232), 1019\u20131022 (2009).","journal-title":"Nature"},{"issue":"1","key":"45476_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/sj.cdd.4401156","volume":"10","author":"I Lavrik","year":"2003","unstructured":"Lavrik, I. et al. The active caspase-8 heterotetramer is formed at the CD95 DISC. Cell. Death Differ. 10 (1), 144\u2013145 (2003).","journal-title":"Cell. Death Differ."},{"key":"45476_CR80","doi-asserted-by":"publisher","first-page":"117600","DOI":"10.1016\/j.jep.2023.117600","volume":"322","author":"J Li","year":"2024","unstructured":"Li, J. et al. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis. J. Ethnopharmacol. 322, 117600 (2024).","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"45476_CR81","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/ddr.21981","volume":"83","author":"GS Lin","year":"2022","unstructured":"Lin, G. S. et al. Palmatine attenuates hepatocyte injury by promoting autophagy via the AMPK\/mTOR pathway after alcoholic liver disease. Drug Dev. Res. 83 (7), 1613\u20131622 (2022).","journal-title":"Drug Dev. Res."},{"key":"45476_CR82","doi-asserted-by":"publisher","first-page":"115453","DOI":"10.1016\/j.jep.2022.115453","volume":"296","author":"X Ai","year":"2022","unstructured":"Ai, X. et al. Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1\u03b1\/VEGF\/DLL-4\/Notch-1 pathway. J. Ethnopharmacol. 296, 115453 (2022).","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"45476_CR83","doi-asserted-by":"publisher","first-page":"105731","DOI":"10.1016\/j.arabjc.2024.105731","volume":"17","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Palmatine ameliorates cisplatin-induced acute kidney injury through regulating Akt and NF-\u03baB\/MAPK pathways. Arab. J. Chem. 17 (5), 105731 (2024).","journal-title":"Arab. J. Chem."},{"issue":"2","key":"45476_CR84","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00071668.2023.2296929","volume":"65","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Antiviral effect of palmatine against infectious bronchitis virus through regulation of NF-\u03baB\/IRF7\/JAK-STAT signalling pathway and apoptosis. Br. Poult. Sci. 65 (2), 119\u2013128 (2024).","journal-title":"Br. Poult. Sci."},{"key":"45476_CR85","doi-asserted-by":"crossref","unstructured":"Selase, A., Cynthia, D. A. & Newman, O. et al. Palmatine modulates triple negative mammary carcinoma by regulating the endogenous function of P53, P21 and Mdm2. Biomed. Pharmacol. J. 14(2), 943\u2013954 (2021).","DOI":"10.13005\/bpj\/2195"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45476-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45476-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:02:01Z","timestamp":1776301321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45476-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45476"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45476-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is reported in accordance with the ARRIVE guidelines and was approved by the Ethics Committee of Heilongjiang University of Traditional Chinese Medicine (Institutional Animal Use License: SYXK-2020-004; ethical approval number: 2023113008).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Intravenous injection of Zoletil\u212250, followed by cervical dislocation to induce death after anesthesia.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Euthanasia method"}}],"article-number":"12464"}}